Cart
sales@molnova.com
RU 24969 hemisuccinate
CAS No. 66611-27-6
RU 24969 hemisuccinate ( —— )
Catalog No. M27644 CAS No. 66611-27-6
RU 24969 is a selective agonist at the 5-HT1A and 5-HT1B receptors.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 43 | Get Quote |
|
| 5MG | 65 | Get Quote |
|
| 10MG | 84 | Get Quote |
|
| 25MG | 185 | Get Quote |
|
| 50MG | 320 | Get Quote |
|
| 100MG | 476 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameRU 24969 hemisuccinate
-
NoteResearch use only, not for human use.
-
Brief DescriptionRU 24969 is a selective agonist at the 5-HT1A and 5-HT1B receptors.
-
DescriptionRU 24969 is a selective agonist at the 5-HT1A and 5-HT1B receptors.
-
Synonyms——
-
PathwayEndocrinology/Hormones
-
Target5-HT Receptor
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number66611-27-6
-
Formula Weight574.7
-
Molecular FormulaC32H38N4O6
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESc1(ccc2c(c1)c(c[nH]2)C1=CCNCC1)OC.C(=O)(CCC(=O)O)O.c1(ccc2c(c1)c(c[nH]2)C1=CCNCC1)OC
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Hirose K, et al. Boron neutron capture therapy using cyclotron-based epithermal neutron source and borofalan (10B) for recurrent or locally advanced head and neck cancer (JHN002): An open-label phase II trial. Radiother Oncol. 2021 Feb;155:182-187.
molnova catalog
related products
-
Sultiame
Sultiame is an inhibitor of carbonic anhydrase. Sultiame can be used in antiepileptic research.
-
Cynanoside F
Cynanoside F is a natural product for research related to life sciences.
-
L-168049
human glucagon receptor (hGR) antagonist.
